SYNAPTIC PHARMACEUTICAL CORP
Industrials · Services-Commercial Physical & Biological Research · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annualNo structured XBRL financials available (common for pre-2009 filers, foreign issuers, or companies that never reported as a US public company).
Material events
SEC Form 8-K · most recent- Item 1 · Item 5 · Item 7Mar 6, 2003
- Item 5 · Item 7Mar 4, 2003
- Item 5 · Item 7Feb 11, 2003
- Item 5 · Item 7Nov 22, 2002
- Item 9Aug 14, 2002
- Item 5Nov 27, 2001
- Item 5Sep 28, 2001
- Item 5Aug 6, 2001
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- SC 13G/ASCHEDULE 13G AMENDMENT NO. 6Feb 13, 2004
- POS AMMar 7, 2003
- S-8 POSMar 7, 2003
- SC 13D/AAMENDMENT NO. 3Mar 7, 2003
- 15-12GMar 7, 2003
- SC 13D/AMar 6, 2003
- 4FORM 4Mar 6, 2003
- SC 13D/AAMENDMENT NO. 1Mar 6, 2003
- 8-KMar 6, 2003
- 8-KMar 4, 2003
- 424B3SYNAPTIC PHARMACEUTICAL CORPORATIONFeb 27, 2003
- 8-KFeb 11, 2003
- SC 13G/AFeb 7, 2003
- SC 13G/ASYNAPTIC PHARMACEUTICAL CORPORATIONFeb 4, 2003
- SC 13DJan 13, 2003
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.